ESR1 and breast cancer: A breast cancer study using IHC of 160 primary breast carcinomas revealed that higher RACK1 expression was correlated with shorter overall survival, and suggested a correlation between RACK1 and the commonly used clinicopathological biomarkers (e.g., Ki-67 and ER) in breast cancer18.